Clinical Trial Update: Streptococcus Salivarius K12@Lip@GSH Alleviates Oral Mucositis in Patients Undergoing Radiotherapy [Phase 1]

View source ↗

Summary

Phase 1 trial results suggest that Streptococcus salivarius K12 liposomal glutathione formulation may alleviate oral mucositis in patients undergoing radiothera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Mucositis

Drugs mentioned

• Streptococcus Salivarius K12@Lip@GSH (Streptococcus salivarius K12 liposomal glutathione formulation)

Snippet

Sponsor: The General Hospital of Western Theater Command | Conditions: Oral Mucositis | Phase 1 | Status: COMPLETED